Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleFirst-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.AuthorsYeh, Randy; O'Donoghue, Joseph A.; Jayaprakasam, Vetri Sudar; Mauguen, Audrey; Min, Ryan; Park, Sue; Brockway, Julia P.; Bromberg, Jacqueline F.; Zhi, W. Iris; Robson, Mark E.; Sanford, Rachel; Modi, Shanu; Agnew, Brian J.; Lyashchenko, Serge K.; Lewis, Jason S.; Ulaner, Gary A.; Zeglis, Brian M.PublicationJournal of Nuclear Medicine, 2024, Vol 65, Issue 3, p386ISSN0161-5505Publication typeArticleDOI10.2967/jnumed.123.266392